Drug Type CAR-T |
Synonyms AntiFR alpha CAR T cell therapy, Antifolate receptor alpha CAR T cell therapy, TmFR 01 CART |
Target |
Mechanism FOLR1 antagonists(Folate receptor alpha antagonists), Gene transference, T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ovarian Epithelial Carcinoma | Phase 1 | US | Tmunity Therapeutics, Inc.Startup | 11 Dec 2020 |